Lopinavir/Ritonavir/Lamivudine/Zidovudine | Interleukin Related interleukin-related.com

Product Name :
Lopinavir/Ritonavir/Lamivudine/Zidovudine

Search keywords :
Lopinavir

drugId :
null

Target Vo:
Human immunodeficiency virus type 1 reverse transcriptase

Target Vo Short Name :
HIV-1 RT

Moa_Name:
Human immunodeficiency virus type 1 protease inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cipla Inc

Active Company_Name :
Cipla Inc

Active Indication_Name:
HIV Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PI3 Kinase p110 gamma (Y10P59) Mouse mAb Epigenetic Reader Domain
Abelacimab Metabolic Enzyme/Protease
BRCA1 Antibody (YA819): BRCA1 Antibody (YA819) is a non-conjugated and Mouse origined monoclonal antibody about 208 kDa, targeting to BRCA1. It can be used for IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts